Delivery Order SPE2DB22D2206-SPE2DB25FHB69
Award Date
5/21/25
Potential Completion Date
6/12/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a pharmaceutical product. The contract has a ceiling value of $5,526.76 and is a firm fixed-price contract. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC)...
The U.S. government agency Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,526.76 contract is to provide XERMELO 250 MG TABLET 84S, a pharmaceutical product, through March 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $5,526.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of March 31, 2025 and was awarded on March 10, 2025. This contract award is associated with a larger Indefinite Delivery...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FGB40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,526.76 firm fixed-price delivery order contract, which runs through April 2, 2025, is for the supply of XERMELO 250 MG TABLET 84S, a medical product. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide XERMELO 250 MG TABLET 84S for a potential value of $9,232.06. The contract has a completion date of March 1, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceutical products and medical supplies to the Department of Defense under...
This delivery order for $9,295.70, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for the purchase of 84 boxes of XERMELO 250 MG tablets with a completion date of November 6, 2023. The contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania by Amerisourcebergen Drug Corporation's Corporate Office as the prime contractor. No set-aside designation was used for this procurement. The Defense Logistics Agency supports America's armed...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XELJANZ XR 11 MG TABLET, a specialty pharmaceutical product, and has a ceiling value of $3,472.13. The contract is a firm fixed price agreement and has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication XELJANZ XR 11 MG TABLET UU 30S, with a ceiling value of $10,006.50 and a performance period through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $3,118.90 and a performance period ending on May 15, 2025. The contract is a Firm Fixed Price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,084.42, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has a period of performance through April 17, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...